Ehrlichia
Obligately intracellular Gram-negative bacteria
arget Cells: myeloid cells, hepatocytes, endothelial cells
Ehrlichia reside in a phagosome within infected cells in two forms Reticulate and Dense core forms: EM picture
Ehrlichia lack LPS and peptidoglycan
Ehrlichia hijack host cell cholesterol to enter and replicate within target cells.
Ehrlichia exploit autophagy protein to obtain nutrients for their survival and replication.
Have type 1 and type IV secretion systems and & several secreted tandem repeat proteins
Ismail N, Bloch KC, McBride JW. Human ehrlichiosis and anaplasmosis. Clin Lab Med. 2010 Mar;30(1):261-92. doi: 10.1016/j.cll.2009.10.004.
Life Cycle
Life Cycle of Amblyomma americanum that transmit the agent of human monocytic ehrlichiosis
Ismail N, Bloch KC, McBride JW. Human ehrlichiosis and anaplasmosis. Clin Lab Med. 2010 Mar;30(1):261-92. doi: 10.1016/j.cll.2009.10.004.
Animal Model of Ehrlichiosis
Ismail N, Bloch KC, McBride JW. Human ehrlichiosis and anaplasmosis. Clin Lab Med. 2010 Mar;30(1):261-92. doi: 10.1016/j.cll.2009.10.004.
Challenges in Ehrlichiosis
Challenges in Diagnosis
- Nonspecific clinical manifestation
- Lack of gold standard laboratory test limitations of serology, PCR, culture
Challenges in Treatment
- Resistance to commonly used antibiotics for Gram negative bacteria
- Late Doxycycline treatment is ineffective
Challenges in Prevention
- Vaccine is not available.
Pathogenesis of Ehrlichiosis
Pathogenesis of Ehrlichiosis
Model of inflammasome activation via canonical and non-canonical pathways
Ismail N, Sharma A, Soong L, Walker DH. Review: Protective Immunity and Immunopathology of Ehrlichiosis. Zoonoses (Burlingt). 2022 Jan 6;2(1):10.15212/zoonoses-2022-0009. doi: 10.15212/zoonoses-2022-0009